Trial · NCT05112354
Predictive Factors for Recovery in Idiopathic Sensory Neural Hearing Loss
NCT05112354, Phase 2, Completed, Assiut University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Predictive Factors for Recovery in Idiopathic Sensory Neural Hearing Loss. Trials, record NCT05112354. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05112354
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Predictive Factors for Recovery in Idiopathic Sensory Neural Hearing Loss
- NCT number
- NCT05112354
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 40 participants, actual
- Lead sponsor
- Assiut University
- Conditions
- Idiopathic Sudden SNHL
- Interventions
- systemic and intratympanic injection of steoid
- First posted
- 2021-11-08
- Last updated
- 2021-11-08
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | To detect if the duration between onset symptoms and start treatment ( in days) affect final hearing prognosis ( in decibel ) | 18months | To detect if the duration between onset symptoms and start treatment ( in days) affect final hearing prognosis( in decibel) assessed by audiogram pre and post treatment |
| Primary | to detect if presence of comorbidities ( diabetes, hypertension, coronary heart diseases and chronic kidney disease ) affect the final hearing prognosis in decibel | 18months | to detect if presence of comorbidities ( diabetes, hypertension, coronary heart diseases) from history taking affect the final hearing prognosis measured by decibel assessed by audiogram pre and post treatment |
| Primary | To detect if the severity of hearing loss symptoms in (decibel ) affect final hearing prognosis ( in decibel ) | 18 months | To detect if the degree of hearing loss symptoms in (decibel) affect final hearing assessed by audiogram pre and post treatmentprognosis ( in s assessed by audiogram pre and post treatment |
| Primary | To detect if presence of associated presenting symptoms ( vertigo and tinnitus) affect the final hearing prognosis | 18 months | To detect if presence of associated presenting symptoms ( vertigo and tinnitus) affect the final hearing prognosis ( in decibel) assessed by audiogram pre and post treatment |
| Secondary | To detect if the age in years affect the final hearing prognosis | 18 months | To detect if the age in years affect the final hearing prognosis assessed by audiogram pre and post treatment |
| Secondary | to detect if unilateral or bilateral symptoms affect the final hearing prognosis | 18 months | to detect if unilateral or bilateral symptoms affect the final hearing prognosis assessed by pre and post treatment audiogram |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers12
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05112354
GET https://conductscience.org/api/trials/v1/NCT05112354/registered